This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
English to Portuguese: Compostos e métodos para tratar infecções fúngicas General field: Law/Patents Detailed field: Medical: Pharmaceuticals
Source text - English This is a multicenter, open-label, non-comparative, single-arm study to evaluate the efficacy and safety of Compound 1 for the first-line treatment for candidemia including suspected or confirmed antifungal-resistant candidemia in non-neutropenic patients 18 to 80 years of age (inclusive).
Translation - Portuguese Esse é um estudo de segmento único, não comparativo, aberto e multicêntrico para avaliar a eficácia e segurança do Composto 1 para o tratamento de primeira linha contra candidemia, incluindo candidemia com resistência antifúngica suspeita ou confirmada em pacientes não neutropênicos de 18 a 80 anos de idade (inclusive).
More
Less
Experience
Years of experience: 13. Registered at ProZ.com: Mar 2021.
Expertise